Therapy of Relapsed AML With Chemotherapy and Dendritic Cell Activated Lymphocytes

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2001

Primary Completion Date

January 14, 2003

Study Completion Date

January 14, 2003

Conditions
Acute Myelogenous LeukemiaChronic Myelogenous Leukemia
Interventions
BIOLOGICAL

Dendritic Cell Activated Lymphocyte

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Immunex Corporation

INDUSTRY

collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER